I have spoken with Jason on this subject and their burn rate is roughly $180 k per month. The next financials will show that to be the case. Significant $ have been spent on work being done on the Nexus and Origin facilities but that is pretty much done now. They still have $10-11 mil in the bank and will be adding close to $7 mil to that this month from sales to Bioscience and Sequoya.
They are not dead, not broke or even close to either. The rest of this month and December will prove that out. They have used their money wisely and will never have to do a raise again. Revenue just starting now and should be close to $30 mil from December through February. That's their next financial quarter.
Additonally, they will be quick to show revenue from November. Once they do they can announce more isolate deals (remember from the last NR "new and existing customers". My understanding is that neutraceutical deals are also in the works.